A variant in FTO shows association with melanoma risk not due to BMI

Juliette A. Randerson‐Moor(University of Leeds), Nicholas G. Martin(The University of Queensland), Shenying Fang(The University of Texas MD Anderson Cancer Center), Nienke van der Stoep(Leiden University Medical Center), Nelleke A. Gruis(Leiden University), Christopher I. Amos(Dartmouth College), Stuart MacGregor(QIMR Berghofer Medical Research Institute), Mark M. Iles(Cancer Research UK), Eitan Friedman(Sheba Medical Center), Matthew H. Law(Queensland University of Technology), Paola Ghiorzo(Ospedale Policlinico San Martino), Ruth M. Pfeiffer(National Cancer Institute), Simon Stacey(deCODE Genetics (Iceland)), Egbert Bakker(Leiden University Medical Center), Nicholas K. Hayward(QIMR Berghofer Medical Research Institute), Mark Harland(Cancer Research UK), Fengju Song(Brigham and Women's Hospital), Alisa M. Goldstein(National Institutes of Health), Jennifer H. Barrett(University of Leeds), Lars A. Akslen(Haukeland University Hospital), Mingfeng Zhang(National Institutes of Health), Anders Molven(Haukeland University Hospital), John Taylor(Cancer Research UK), Maria Teresa Landi(National Institutes of Health), Giovanna Bianchi‐Scarrà(University of Genoa), Julia Newton‐Bishop(National Cancer Institute), Jiali Han(Brigham and Women's Hospital), Patrick Sulem(deCODE Genetics (Iceland)), D. Timothy Bishop(University of Leeds), Wilma Bergman(Leiden University Medical Center), Marie-Françoise Avril(Délégation Paris 5), Helen Snowden(St James's University Hospital), Esther Azizi(Tel Aviv University)
Nature Genetics
March 3, 2013
Cited by 132


Related Papers